Biodesix Cuts Full-Year Outlook After Operational Shortcomings Hurt Growth
Biodesix cut its full-year outlook, citing operational shortcomings that hurt growth in the recent quarter. Its shares fell roughly a third in premarket trading Friday.
By Connor HartShares of Biodesix fell after the company cut its full-year outlook, citing operational shortcomings that hurt growth during the recent quarter.The stock lost roughly a third of its value in premarket trading Friday. Through Thursday's close, shares have roughly tripled year to date.T…